Deborah A Altomare Selected Research

Deborah A Altomare Research Topics

Disease

35	Neoplasms (Cancer) 01/2024 - 01/2002
10	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 01/2002
7	Carcinogenesis 10/2022 - 01/2002
7	Ovarian Neoplasms (Ovarian Cancer) 02/2016 - 07/2004
7	Malignant Mesothelioma 04/2011 - 06/2005
7	Carcinoma (Carcinomatosis) 08/2010 - 01/2002
4	Adenocarcinoma 10/2022 - 11/2004
4	Mesothelioma 04/2011 - 02/2008
2	Chronic Pancreatitis 01/2022 - 01/2020
2	Inflammation (Inflammations) 01/2022 - 01/2020
2	Neoplasm Metastasis (Metastasis) 02/2015 - 05/2014
1	Gastroesophageal Reflux (GERD) 10/2022
1	Barrett Esophagus (Barrett's Esophagus) 10/2022
1	Disease Progression 10/2022
1	Pancreatitis 01/2022
1	Stomach Neoplasms (Stomach Cancer) 12/2021
1	Chromosomal Instability (Chromosome Stability) 12/2021
1	Duodenogastric Reflux 12/2021
1	Insulin Resistance 01/2016
1	Hyperglycemia 01/2016
1	Diabetes Mellitus 01/2016
1	Prediabetic State (Prediabetes) 01/2016
1	Glucose Intolerance 01/2016
1	Carcinoma in Situ 02/2015
1	Lymphoma (Lymphomas) 01/2010

Drug/Important Bio-Agent (IBA)

5	PolyaminesIBA 12/2021 - 11/2004
5	Proteins (Proteins, Gene)FDA Link 12/2021 - 11/2004
5	Cisplatin (Platino)FDA LinkGeneric 03/2017 - 07/2004
5	AsbestosIBA 04/2011 - 06/2005
4	CytokinesIBA 01/2024 - 01/2018
4	Eflornithine (Ornidyl)FDA Link 01/2021 - 11/2004
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2010 - 03/2007
3	TOR Serine-Threonine KinasesIBA 09/2009 - 03/2007
3	Everolimus FDA Link 09/2009 - 03/2007
3	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 06/2007 - 05/2002
2	EnzymesIBA 10/2022 - 01/2021
2	5- iodo- 3- ((3,5- dibromo- 4- hydroxyphenyl)methylene)- 2- indolinoneIBA 12/2021 - 01/2021
2	Ornithine Decarboxylase (Decarboxylase, Ornithine)IBA 01/2021 - 11/2004
2	AntibodiesIBA 01/2017 - 01/2010
2	Biomarkers (Surrogate Marker)IBA 01/2016 - 02/2015
2	Protein Isoforms (Isoforms)IBA 01/2016 - 02/2015
2	Proto-Oncogene Proteins c-akt (Protein Kinase B)IBA 01/2016 - 01/2002
2	Phosphotransferases (Kinase)IBA 09/2005 - 01/2002
2	2- (4- morpholinyl)- 8- phenyl- 4H- 1- benzopyran- 4- oneIBA 07/2004 - 05/2002
1	Interleukin-15 (Interleukin 15)IBA 01/2024
1	Interleukin-18 (Interleukin 18)IBA 01/2024
1	Interleukin-12 (IL 12)IBA 01/2024
1	Carnitine (L-Carnitine)FDA LinkGeneric 10/2022
1	Interleukin-8 (Interleukin 8)IBA 10/2022
1	Fatty Acids (Saturated Fatty Acids)IBA 10/2022
1	Fluorescent Dyes (Fluorescent Probes)IBA 10/2022
1	Palmitic Acid (Hexadecanoic Acid)IBA 10/2022
1	Deoxycholic Acid (Sodium Deoxycholate)IBA 10/2022
1	LipidsIBA 10/2022
1	Cholecystokinin (Pancreozymin)IBA 01/2022
1	CeruletideIBA 01/2022
1	Messenger RNA (mRNA)IBA 12/2021
1	Pregnane X ReceptorIBA 12/2021
1	Sphingosine-1-Phosphate ReceptorsIBA 12/2021
1	Constitutive Androstane ReceptorIBA 12/2021
1	Bile Acids and Salts (Bile Acids)IBA 12/2021
1	GTP-Binding Proteins (G-Protein)IBA 12/2021
1	Cholinergic Agents (Cholinergics)IBA 12/2021
1	Cholinergic ReceptorsIBA 12/2021
1	SpermidineIBA 01/2021
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	Immune Checkpoint InhibitorsIBA 01/2018
1	Gemcitabine FDA Link 01/2018
1	Platinum Compounds (Compounds, Platinum)IBA 03/2017
1	Monoclonal AntibodiesIBA 01/2017
1	AntigensIBA 01/2017
1	taxaneIBA 02/2016
1	PlatinumIBA 02/2016
1	Granzymes (Granzyme)IBA 02/2016
1	Insulin (Novolin)FDA Link 01/2016
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Glucagon (Glukagon)FDA Link 01/2016
1	Doxycycline (Periostat)FDA LinkGeneric 01/2016
1	Insulin ReceptorIBA 01/2016
1	Caveolin 1IBA 01/2016
1	MucinsIBA 02/2015
1	dihydromotuporamine CIBA 05/2014
1	Tumor Suppressor Protein p14ARF (p14ARF)IBA 04/2011
1	Cyclin-Dependent Kinase Inhibitor p16IBA 04/2011
1	Bevacizumab (Avastin)FDA Link 08/2010
1	ranpirnase (Pannon)IBA 02/2010
1	Interleukin-6 (Interleukin 6)IBA 02/2010
1	RNA (Ribonucleic Acid)IBA 02/2010
1	GSK690693IBA 01/2010
1	NF-kappa B (NF-kB)IBA 03/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2009
1	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 02/2008
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 02/2008
1	fos-related antigen 1IBA 02/2008
1	LigandsIBA 02/2008
1	thiazolyl blueIBA 07/2007

Therapy/Procedure

9	Therapeutics 01/2024 - 06/2005
3	Immunotherapy 01/2022 - 04/2015
2	Drug Therapy (Chemotherapy) 02/2016 - 09/2005
1	Cell- and Tissue-Based Therapy (Cell Therapy) 02/2016